Veliparib, Paclitaxel, and Carboplatin in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery and Liver or Kidney Dysfunction
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
SWOG Cancer Research Network
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Pfizer
Eli Lilly and Company
Revolution Medicines, Inc.
Memorial Sloan Kettering Cancer Center
Amgen
USWM, LLC (dba US WorldMeds)
Seagen Inc.
National Institutes of Health Clinical Center (CC)
EMD Serono
Arcus Biosciences, Inc.
Agenus Inc.
City of Hope Medical Center
National Cancer Institute (NCI)
Eli Lilly and Company
Hoffmann-La Roche
Duke University
AstraZeneca
Poseida Therapeutics, Inc.
AstraZeneca
Seagen Inc.
Novartis
University Health Network, Toronto
NeoTX Therapeutics Ltd.
BicycleTx Limited
SystImmune Inc.
TCR2 Therapeutics
TCR2 Therapeutics
Exelixis
Sensei Biotherapeutics, Inc.
Jonsson Comprehensive Cancer Center
Cancer Research UK
OncoC4, Inc.
Compugen Ltd
Tempus AI
Carisma Therapeutics Inc
NextCure, Inc.
NGM Biopharmaceuticals, Inc
NGM Biopharmaceuticals, Inc
Baltimore VA Medical Center
Comprehensive Support Project for Oncology Research
Adaptimmune
ImmunoVaccine Technologies, Inc. (IMV Inc.)